18 Einträge gefunden

1. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
2. Assays for prostate cancer: changing the screening paradigm?

   1. Hansen, Jens
   2. Rink, Michael
   3. Graefen, Markus
   4. Shariat, Shahrokh
   5. Chun, Felix K-H

   2013 - Forschungsinformationssystem des UKE
3. Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.

   1. Trinh, Quoc-Dien
   2. Sukumar, Shyam
   3. Schmitges, Jan
   4. Bianchi, Marco
   5. Sun, Maxine
   6. Shariat, Shahrokh F
   7. Sammon, Jesse D

   2013 - Forschungsinformationssystem des UKE
4. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
5. From diagnostic tool to disease monitoring: the growing role of prostate biopsies.

   1. Graefen, Markus
   2. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
6. Marked heterogeneity of ERG expression in large primary prostate cancers.

   1. Minner, Sarah
   2. Gärtner, Michael
   3. Freudenthaler, Fabian
   4. Bauer, Melanie
   5. Kluth, Martina
   6. Salomon, Georg
   7. Heinzer, Hans

   2013 - Forschungsinformationssystem des UKE
7. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

   1. Grupp, Katharina
   2. Sanader, Stella
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Koop, Christina
   6. Prien, Kristina
   7. Hube-Magg, Claudia

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
8. An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysis.

   1. Bianchi, Marco
   2. Becker, Andreas
   3. Trinh, Quoc-Dien
   4. Abdollah, Firas
   5. Tian, Zhe
   6. Shariat, Shahrokh F
   7. Montorsi, Francesco

   2013 - Forschungsinformationssystem des UKE
9. High mitochondria content is associated with prostate cancer disease progression

   1. Grupp, Katharina
   2. Jedrzejewska, Karolina
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Quaas, Alexander

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
10. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

    1. Krohn, Antje
    2. Seidel, Annemarie
    3. Burkhardt, Lia
    4. Bachmann, Frederik
    5. Mader, Malte
    6. Grupp, Katharina
    7. Eichenauer, Till

    2013 - Forschungsinformationssystem des UKE
11. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.

    1. Hansen, Jens
    2. Rink, Michael
    3. Bianchi, Marco
    4. Kluth, Luis A
    5. Tian, Zhe
    6. Ahyai, Sascha A
    7. Shariat, Shahrokh F

    2013 - Forschungsinformationssystem des UKE
12. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis

    1. Briganti, Alberto
    2. Spahn, Martin
    3. Joniau, Steven
    4. Gontero, Paolo
    5. Bianchi, Marco
    6. Kneitz, Burkhard
    7. Chun, Felix K H

    2013 - Forschungsinformationssystem des UKE
13. Sociodemographic disparities in the treatment of small renal masses.

    1. Becker, Andreas
    2. Roghmann, Florian
    3. Trinh, Quoc-Dien
    4. Hansen, Jens
    5. Tian, Zhe
    6. Shariat, Shahrokh F
    7. Noldus, Joachim

    2013 - Forschungsinformationssystem des UKE
14. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

    1. Burkhardt, Lia
    2. Fuchs, Sarah
    3. Krohn, Antje
    4. Masser, Sawinee
    5. Mader, Malte
    6. Kluth, Martina
    7. Bachmann, Frederik

    2013 - Forschungsinformationssystem des UKE
15. Active surveillance for low-risk prostate cancer: some questions are answered, but many questions remain.

    1. Graefen, Markus
    2. Schlomm, Thorsten

    2013 - Forschungsinformationssystem des UKE
16. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

    1. Krohn, Antje
    2. Seidel, Annemarie
    3. Burkhardt, Lia
    4. Bachmann, Frederic
    5. Mader, Malte
    6. Grupp, Katharina
    7. Eichenauer, Till

    2013 - Forschungsinformationssystem der UHH
17. Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?

    1. Leyh-Bannurah, Sami-Ramzi
    2. Hansen, Jens
    3. Isbarn, Hendrik
    4. Steuber, Thomas
    5. Tennstedt, Pierre
    6. Michl, Uwe
    7. Schlomm, Thorsten

    2013 - Forschungsinformationssystem des UKE
18. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

    1. Grupp, Katharina
    2. Höhne, Thorsten Simon
    3. Prien, Kristina
    4. Hube-Magg, Claudia
    5. Tsourlakis, Maria Christina
    6. Sirma, Hüseyin
    7. Pham, Taher

    2013 - Forschungsinformationssystem des UKE